About | Home | Search
Pubget
Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Autoimmune Diseases (21):
  • Pemphigus
  • Glomerulonephritis, Membranous
  • Familial Mediterranean Fever
  • Anti-Glomerular Basement Membrane Disease
  • Lambert-Eaton Myasthenic Syndrome
  • Thyroiditis, Autoimmune
  • Hepatitis, Autoimmune
  • Diabetes Mellitus, Type 1
  • Ophthalmia, Sympathetic
  • Glomerulonephritis, IGA
  • Addison Disease
  • Lupus Erythematosus, Systemic
  • Autoimmune Diseases of the Nervous System
  • Arthritis, Rheumatoid
  • Purpura, Thrombocytopenic, Idiopathic
  • Pemphigoid, Bullous
  • Graves Disease
  • Antiphospholipid Syndrome
  • Polyendocrinopathies, Autoimmune
  • Anemia, Hemolytic, Autoimmune
  • Dermatitis Herpetiformis
Home > Immune System Diseases > Autoimmune Diseases

Recent article

Autoimmune Diseases

Pancreas (40)7 2011
Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis.
Takeo Kusuda, Kazushige Uchida, Hideaki Miyoshi, Masanori Koyabu, Sohei Satoi, Makoto Takaoka, Nobuaki Shikata, Yoshiko Uemura and Kazuichi Okazaki
Abstract
We studied Tregs in the pancreas and peripheral blood. We recruited 44 patients with IgG4-related AIP. For comparison, we recruited 37 patients with other pancreatic diseases and 27 healthy subjects as controls. We studied infiltrating cells in the pancreas by immunohistochemistry an... | PMID: 21926547

Large_pdficon_selected PDF is available here.
< More recent Older article >
New England Journal of Medicine (365)13 2011
Case records of the Massachusetts General Hospital. Case 30-2011. A 62-year-old woman with renal failure.
John Cunningham, Mukesh G Harisinghani and Diana Taheri
Abstract
PMID: 21991897

Large_pdficon_selected PDF is available here.
Methods in Molecular Biology (677) 2011
Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
Maria Cristina Cuturi, Ignacio Anegon, Leandro J Carreño, Claudia A Riedel and Alexis M Kalergis
Abstract
We have shown, both in vitro and in vivo, that NF-κB blockade on DCs by andrographolide or rosiglitazone can significantly enhance the tolerogenic capacity of DCs. Furthermore, we have observed that expression ratio of the activating FcγRIII or the inhibitory FcγRIIb is determinant for the tolero... | PMID: 20941620

Large_pdficon_selected PDF is available here.
Journal of Clinical Investigation (121)9 2011
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.
Qing Ding, Melissa Yeung, Geoffrey Camirand, Qiang Zeng, Hisaya Akiba, Hideo Yagita, Geetha Chalasani, Mohamed H Sayegh, Nader Najafian and David M Rothstein
Abstract
We show that in vivo in mice, TIM-1 is predominantly expressed on B rather than T cells. Importantly, TIM-1 was expressed by a large majority of IL-10-expressing regulatory B cells in all major B cell subpopulations, including transitional, marginal zone, and follicular B cells, as well as the B cel... | PMID: 21821911

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (10)11 2011
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature.
Guillermo J Pons-Estel, Gabriel E Salerni, Rosa M Serrano, José A Gomez-Puerta, Miguel A Plasin, Edelweiss Aldasoro, Miguel Lozano, Joan Cid, Ricard Cervera and Gerard Espinosa
Abstract
We included all patients with systemic autoimmune diseases in whom the indication for treatment with TPE was a flare of the disease between 1999 and 2010. The indications for treatment, complications and outcomes were obtained from review of medical records. A total of 31 patients (1... | PMID: 21569864

Large_pdficon_selected PDF is available here.
Nagoya journal of medical science (73)3-4 2011
CD40/CD40 ligand interactions in immune responses and pulmonary immunity.
Tsutomu Kawabe, Miyoko Matsushima, Naozumi Hashimoto, Kazuyoshi Imaizumi and Yoshinori Hasegawa
Abstract
We will discuss the involvement of the CD40 ligand/CD40 interaction in the pathophysiology of inflammatory diseases, including autoimmune diseases, atherothrombosis, cancer, and respiratory diseases.... | PMID: 21928689

Large_pdficon_selected PDF is available here.
Folia Pharmacologica Japonica (138)2 2011
[autoimmune pulmonary alveolar proteinosis and GM-CSF inhalation therapy].
Ryushi Tazawa and Koh Nakata
Abstract
PMID: 21828940

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)7 2011
Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.
Sheinei J Saleem and Daniel H Conrad
Abstract
Hematopoietic stem cells (HSCs) differentiate into mature lineage restricted blood cells under the influence of a complex network of hematopoietic cytokines, cytokine-mediated transcriptional regulators, and manifold intercellular signaling pathways. The classical model of hematopoie... | PMID: 21426948

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)7 2011
Meeting report: regulatory myeloid cells.
Drake LaFace and James Talmadge
Abstract
Recent investigations of regulatory myeloid cell mobilization and amplification in response to cancer and chronic inflammation associated with infectious disease and autoimmunity have provided numerous insights into the suppressive mechanisms, pathobiology and potential pharmaceutica... | PMID: 21315784

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)6 2011
C reactive protein as a predictor of neutrophil recovery in autoimmune neutropenia.
Chiharu Tabata, Rie Tabata, Hidemi Kitai, Tomoko Nagai and Takashi Nakano
Abstract
We report a successful management of primary AIN patient by estimating the granulopoiesis according to CRP levels without administration of G-CSF or increase of prednisolone when peripheral neutrophil counts dropped down. Transient elevation of CRP associated with severe drop down in neutrophil coun... | PMID: 21316504

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)6 2011
Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model.
Xiangrong Ren, Hongyan Zhou, Bing Li and Shao Bo Su
Abstract
We analyzed the effects of systemic delivery of polyinosinic:polycytidylic acid (poly(I:C)), a mimic of viral dsRNA, in the induction of EAU. We found that TLR3 agonist poly(I:C) enhanced EAU scores, DTH responses and Ag-specific T cell proliferation. In addition, Ag-specific Interleukin 17 (IL-17)... | PMID: 21296697

Large_pdficon_selected PDF is available here.
Audio, Transactions of the IRE Professional Group on (124)5 2011
Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases.
Manuel M Ramos-Casals, Roberto R Perez-Alvarez, Marta M Perez-de-Lis, Antoni A Xaubet, Xavier X Bosch and
Abstract
Monoclonal antibodies have emerged as a new class of agents causing drug-related pulmonary involvement in patients with systemic rheumatologic autoimmune diseases. The most frequently associated noninfectious pulmonary diseases are interstitial pneumonia (118 cases reported by August 2010), sarcoid-l... | PMID: 21531225

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (10)7 2011
Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity.
Marisa Neves and José Delgado Alves
Abstract
Autoimmune diseases are frequently associated with the production of autoantibodies by cells that escaped the protective mechanisms that control self-tolerance. Some of these cells develop into long-lived plasma cells which are predominantly located in the bone marrow. The generation... | PMID: 21224017

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (10)7 2011
Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Pál Soltész, György Kerekes, Henriett Dér, Gabriella Szücs, Sándor Szántó, Emese Kiss, Edit Bodolay, Margit Zeher, Orsolya Timár, Péter Szodoray, Gyula Szegedi and Zoltán Szekanecz
Abstract
Numerous autoimmune-inflammatory rheumatic diseases have been associated with accelerated atherosclerosis or other types of vasculopathy leading to increased cardio- and cerebrovascular disease risk. Traditional risk factors, as well as the role of systemic inflammation including cyt... | PMID: 21281743

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (10)7 2011
Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus.
Kam A Newman and Mojtaba Akhtari
Abstract
Autoimmune neutropenia, caused by neutrophil-specific autoantibodies is a common phenomenon in autoimmune disorders such as Felty's syndrome and systemic lupus erythematosus. Felty's syndrome is associated with neutropenia and splenomegaly in seropositive rheumatoid arthritis which c... | PMID: 21255689

Large_pdficon_selected PDF is available here.
Revue medicale suisse (7)290 2011
[Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Laila-Yasmin Mani, Bruno Vogt, Michel Burnier and Déla Golshayan
Abstract
Autoimmune glomerulopathies are an important cause of chronic kidney disease. Conventional treatments based on steroids, antiproliferative and cytotoxic agents are efficacious, but highly toxic. Because of their central role in the pathogenesis of autoimmunity, B cells have become an... | PMID: 21595313

Large_pdficon_selected PDF is available here.
Drugs of Today (47)4 2011
Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications.
G G Murdaca, B M BM Colombo and F F Puppo
Abstract
We will briefly review the structure and biological effects of TNF-α, the old and recent indications of adalimumab, the pretreatment considerations, the reported adverse events and finally, the recommendations for its use in pregnancy. 2011 Prous Science, S.A.U. or its licensors. Al... | PMID: 21573251

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)3 2011
Th17 cells in inflammation.
Akihiro Kimura and Tadamitsu Kishimoto
Abstract
Naïve T cells are multipotential precursors that differentiate into various effector subsets, such as T helper type 1 (Th1) and Th2 cells, which are characterized by their distinct functions. The IL-17-producing T helper (Th17) cell has been recently identified as a new subset of th... | PMID: 21035432

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)3 2011
Regulatory role of resveratrol on Th17 in autoimmune disease.
Thomas M Petro
Abstract
The immune system is balanced with cells that respond to microbes by developing into effector cells and cells that regulate the activity of effector cells. In many immune responses a subset of effector T cells termed Th17 are necessary for complete immunity because the cytokine IL-17... | PMID: 20708723

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)3 2011
Immunomodulatory and therapeutic activity of curcumin.
Raghvendra M Srivastava, Sarvjeet Singh, Shiv K Dubey, Krishna Misra and Ashok Khar
Abstract
Inflammation is a disease of vigorous uncontrolled activated immune responses. Overwhelming reports have suggested that the modulation of immune responses by curcumin plays a dominant role in the treatment of inflammation and metabolic diseases. Observations from both in-vitro and in... | PMID: 20828642

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (10)5 2011
Immunogenetics of systemic sclerosis.
P Dieudé, C Boileau and Y Allanore
Abstract
We are currently reaching a period of rapid data production. Several themes are already rising from the first wave of results. First, some genetic variants clearly predispose to multiple autoimmune diseases, thus providing evidence for a shared autoimmune genetic background. Second, multiple genes a... | PMID: 20863905

Large_pdficon_selected PDF is available here.
Nippon rinsho. Japanese journal of clinical medicine (69)3 2011
[Limbic encephalitis up to date].
Morinobu M Seki, Shigeaki S Suzuki and Norihiro N Suzuki
Abstract
We categorized LE into 5 groups. LE caused by virus infection, autoantibody-mediated LE, LE with autoimmune disease, LE associated with drugs and LE during pregnancy. LE having the antibodies against intracellular antigens frequently related to cancer and are resistant to treatment. While, LE with a... | PMID: 21400836

Large_pdficon_selected PDF is available here.
Nippon rinsho. Japanese journal of clinical medicine (69)3 2011
[Pathogenesis of acute encephalitis and acute encephalopathy].
Masashi M Shiomi
Abstract
We proposed the classification of IAE with poor prognosis from the neuroradiological findings. Four types of encephalopathy seem to be differentiated from each other, acute necrotizing encephalopathy (ANE) type, hemorrhagic shock and encephalopathy syndrome (HSES) type, acute brain swelling (ABS) ty... | PMID: 21400830

Large_pdficon_selected PDF is available here.
Journal of Neuroimmunology (231)1-2 2011
Clinical and biological heterogeneity of autoimmune myasthenia gravis.
Jozsef Pal, Csilla Rozsa, Samuel Komoly and Zsolt Illes
Abstract
Although myasthenia gravis (MG) has long been considered a well-established autoimmune disease associated with autoantibodies, which are convincingly pathogenic, accumulating data indicate both clinical and biological heterogeneity similar to many other putative autoimmune disorders.... | PMID: 21093931

Large_pdficon_selected PDF is available here.
Proteomics Clinical Applications (5)1-2 2011
Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
Lucia De Franceschi, Silvia Bosello, Cinzia Scambi, Domenico Biasi, Maria De Santis, Paola Caramaschi, Giusy Peluso, Valentina La Verde, Lisa Maria Bambara and Gianfranco Ferraccioli
Abstract
We addressed four major autoimmune-rheumatological diseases investigated through proteomic techniques and provide evidence-based data on the highlights obtained in systemic sclerosis, primary and secondary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis. Cop... | PMID: 21246742

Large_pdficon_selected PDF is available here.
Immunotherapy (3)2 2011
Conference scene: lessons from animal models of autoimmune diseases: from mechanisms to applications.
Pranab K Das and Graham Elliott
Abstract
We are grateful for their participation. This meeting report describes key points and themes arising from this conference.... | PMID: 21322755

Large_pdficon_selected PDF is available here.
Toxicology (279)1-3 2011
Report about the XVIIIth meeting of the Cancer Research Institute in its international cancer immunotherapy symposium series on October 6-8, 2010.
Stefan Hockertz
Abstract
PMID: 21204306

Large_pdficon_selected PDF is available here.
The American Journal of Surgical Pathology (35)1 2011
Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
Vikram Deshpande, Rajib Gupta, Nisha Sainani, Dushyant V Sahani, Renu Virk, Cristina Ferrone, Arezou Khosroshahi, John H Stone and Gregory Y Lauwers
Abstract
We revisited the subclassification of AIP and examine whether this provides clinically and prognostically meaningful information. We evaluated 29 pancreatic resection specimens from patients with AIP. Demographic, clinical, and imaging data were recorded, as was evidence of extrapancreatic manifesta... | PMID: 21164284

Large_pdficon_selected PDF is available here.
Clinical and Developmental Immunology (2011) 2011
Role of IL-17 and Th17 Cells in Liver Diseases
Linda Hammerich, Felix Heymann and Frank Tacke
Abstract
Unbalanced Th1/Th2 T-cell responses in the liver are a characteristic of hepatic inflammation and subsequent liver fibrosis. The recently discovered Th17 cells, a subtype of CD4(+) T-helper cells mainly producing IL-17 and IL-22, have initially been linked to host defense against inf... | PMID: 21197451

Large_pdficon_selected PDF is available here.
Seminars in Immunopathology (33)1 2011
Innate immunity and the pathogenesis of type 1 diabetes.
Fabio Arturo Grieco, Francesco Vendrame, Isabella Spagnuolo and Francesco Dotta
Abstract
We review the contribution of innate immune response to type 1 diabetes, with a particular emphasis to Toll-like receptors (TLR) and NK cells.... | PMID: 20383637

Large_pdficon_selected PDF is available here.
Seminars in Immunopathology (33)1 2011
Innate immunity and the pathogenesis of type 1 diabetes.
Fabio Arturo Grieco, Francesco Vendrame, Isabella Spagnuolo and Francesco Dotta
Abstract
We review the contribution of innate immune response to type 1 diabetes, with a particular emphasis to Toll-like receptors (TLR) and NK cells.... | PMID: 20383637

Large_pdficon_selected PDF is available here.
Seminars in Immunopathology (33)1 2011
Innate immunity and the pathogenesis of type 1 diabetes.
Fabio Arturo Grieco, Francesco Vendrame, Isabella Spagnuolo and Francesco Dotta
Abstract
We review the contribution of innate immune response to type 1 diabetes, with a particular emphasis to Toll-like receptors (TLR) and NK cells.... | PMID: 20383637

Large_pdficon_selected PDF is available here.
PLoS ONE (6)5 2011
Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
Min Sun, Yan Yang, Peizeng Yang, Bo Lei, Liping Du and Aize Kijlstra
Abstract
Experimental autoimmune uveoretinitis (EAU) serves as a model for human intraocular inflammation. IFN-β has been used in the treatment of certain autoimmune diseases. Earlier studies showed that it ameliorated EAU; however, the mechanisms involved in this inhibition are still largel... | PMID: 21573074

Large_pdficon_selected PDF is available here.
Digestive and Liver Disease (43)1 2011
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
Ambrogio Orlando, Alessandro Armuzzi, Claudio Papi, Vito Annese, Sandro Ardizzone, Livia Biancone, Aurora Bortoli, Fabiana Castiglione, Renata D'Incà, Paolo Gionchetti, Anna Kohn, Gilberto Poggioli, Fernando Rizzello, Maurizio Vecchi, Mario Cottone, Italian Society of Gastroenterology and Italian Group for the study of Inflammatory Bowel Disease
Abstract
Biological therapies are an important step in the management of Inflammatory Bowel Diseases. In consideration of high cost and safety issues there is the need to have clear recommendations for their use. Despite the American Gastroenterological Association and the European Crohn's an... | PMID: 20843756

Large_pdficon_selected PDF is available here.
Medicinski pregled (64)3-4 2011
[Autoimmune thyroid disease and other non-endocrine autoimmune diseases].
Ljiljana Todorović LT Dilas, Tijana T Icin, Jovanka Novaković JN Paro and Ivana I Bajkin
Abstract
Screening for autoimmune thyroid diseases should be recommended in everyday clinical practice, in patients with primary organ-specific or organ non-specific autoimmune disease. Otherwise, in patients with primary thyroid autoimmune disease, there is no good reason of seeking for all other autoimmune... | PMID: 21905597

Large_pdficon_selected PDF is available here.
Advances in Clinical Chemistry (53) 2011
Dipeptidyl peptidase in autoimmune pathophysiology.
Kei Ohnuma, Osamu Hosono, Nam H Dang and Chikao Morimoto
Abstract
We have shown that CD26 interacts with structures with essential cellular functions in T cell responses. We will review emerging data that suggest CD26 may be an appropriate therapeutic target for the treatment of selected immune disorders.... | PMID: 21404914

Large_pdficon_selected PDF is available here.
The American Journal of Surgical Pathology (34)12 2010
IgG4-related disease: a cross-sectional study of 114 cases.
Yoh Zen and Yasuni Nakanuma
Abstract
We carried out a cross-sectional study of 114 patients with IgG4-related disease. On the basis of the location of the lesions, the patients were classified into 5 groups: head and neck (n=23), thoracic (n=16), hepatic and pancreatobiliary (n=27), retroperitoneal (n=13), and systemic (n=35). All grou... | PMID: 21107087

Large_pdficon_selected PDF is available here.
Neuroscience Bulletin (26)6 2010
Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.
Hong-Liang Zhang and Jiang Wu
Abstract
Vitamin D is a seco-steroid involved in calcium and phosphorus metabolism, and bone formation and mineralization, through binding to a specific nuclear receptor, vitamin D receptor (VDR). Besides its well-established functions on bone health, multiple lines of evidence have indicated... | PMID: 21113195

Large_pdficon_selected PDF is available here.
IMAJ (12)12 2010
Frontier issues in autoimmunity: publications in 2009-2010.
Zahava Vadasz and Elias Toubi
Abstract
PMID: 21348405

Large_pdficon_selected PDF is available here.
Nature Immunology (11)12 2010
Multistoried roles for B lymphocytes in autoimmunity.
Masaki Hikada and Moncef Zouali
Abstract
In autoimmune disease, multifaceted approaches are being explored to tailor a particular treatment that targets a specific cell at the appropriate disease stage. The key roles of B lymphocytes have enabled them to enter the clinical arena. In turn, clinical trials have suggested seve... | PMID: 21079626

Large_pdficon_selected PDF is available here.
Journal of Medicinal Chemistry (53)24 2010
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.
Mark E Flanagan, Todd A Blumenkopf, William H Brissette, Matthew F Brown, Jeffrey M Casavant, Chang Shang-Poa, Jonathan L Doty, Eileen A Elliott, Michael B Fisher, Michael Hines, Craig Kent, Elizabeth M Kudlacz, Brett M Lillie, Kelly S Magnuson, Sandra P McCurdy, Michael J Munchhof, Bret D Perry, Perry S Sawyer, Timothy J Strelevitz, Chakrapani Subramanyam, Jianmin Sun, David A Whipple and Paul S Changelian
Abstract
There is a critical need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis. Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines importan... | PMID: 21105711

Large_pdficon_selected PDF is available here.
Epidemiology (21)6 2010
Parental autoimmune diseases associated with autism spectrum disorders in offspring.
Alexander Keil, Julie L Daniels, Ulla Forssen, Christina Hultman, Sven Cnattingius, Karin C Söderberg, Maria Feychting and Par Sparen
Abstract
We explored associations between parental autoimmune disorders and children's diagnosis of autism by linking Swedish registries. Data for each participant were linked across 3 Swedish registries. The study includes 1227 cases and 25 matched controls for each case (30,693 controls with parental linka... | PMID: 20798635

Large_pdficon_selected PDF is available here.
Expert Opinion on Therapeutic Patents (20)11 2010
Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.
Fatih M Uckun and Sanjive Qazi
Abstract
We provide a comprehensive review of the target diseases for which the use of BTK inhibitors may be helpful as well as the activity profiles of BTK inhibitors. We review the currently available translational research, biomarker as well as patent literature regarding BTK molecular target and BTK inhi... | PMID: 20831363

Large_pdficon_selected PDF is available here.
Expert Opinion on Therapeutic Patents (20)11 2010
Update on lymphocyte specific kinase inhibitors: a patent survey.
Matthew W Martin and Michelle R Machacek
Abstract
Lck (p56(lck) or lymphocyte specific kinase) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells. Genetic evidence from knockout mice and human mutations demonstrates that Lck kinase activity is critical for T cell receptor (TCR)-mediated signaling,... | PMID: 20831362

Large_pdficon_selected PDF is available here.
Nippon Ganka Gakkai zasshi (114)11 2010
[The development of therapy for uveitis based on animal model].
Kouichi K Ohta
Abstract
PMID: 21141071

Large_pdficon_selected PDF is available here.
Nippon Ganka Gakkai zasshi (114)11 2010
[Therapeutic effect of the low molecular weight inhibitor of the NF-kappaB signaling pathway on experimental autoimmune uveoretinitis].
Hiroshi H Keino
Abstract
We investigated whether oral administration of STA-5326 is effective in influencing experimental autoimmune uveoretinitis (EAU). Clinical and histopathological analysis of our results show that oral administration of STA-5326 during the entire phase reduced the severity of EAU. Furthermore, oral adm... | PMID: 21141074

Large_pdficon_selected PDF is available here.
Annals of the Rheumatic Diseases (69)11 2010
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
P Dieudé, M Guedj, J Wipff, B Ruiz, G Riemekasten, M Matucci-Cerinic, I Melchers, E Hachulla, P Airo, E Diot, N Hunzelmann, J Cabane, L Mouthon, J L Cracowski, V Riccieri, J Distler, O Meyer, A Kahan, C Boileau and Y Allanore
Abstract
The rs5029939 G allele was found to be significantly associated with SSc susceptibility (pooled OR=2.08 (95% CI 1.59 to 2.72); p=1.16×10⁻⁷), whereas the rs10499194 and rs6920220 variants displayed no association. Only one of the predicted haplotypes investigated in the French sample was signifi... | PMID: 20511617

Large_pdficon_selected PDF is available here.
Current Opinion in Gastroenterology (26)6 2010
Vitamin D and mucosal immune function.
Jun Sun
Abstract
Significant advances have been made in the characterization of Vitamin D and the Vitamin D receptor (VDR) in immune function. The studies of signaling pathways involved in the response to infection and inflammation have led to a more detailed understanding of the cellular response to Vitamin D throu... | PMID: 20639756

Large_pdficon_selected PDF is available here.
The American Journal of Surgical Pathology (34)11 2010
Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting.
Jason Y Park, Toby C Cornish, Dora Lam-Himlin, Chanjuan Shi and Elizabeth Montgomery
Abstract
We investigated the frequency of PGAs and other lesions in all nonconsultation gastric biopsies and resections (1988 to 2008) diagnosed as AMAG. We further selected cases confirmed as AMAG by immunohistochemical identification of the gastric body (negative gastrin) and linear and nodular enterochrom... | PMID: 20975338

Large_pdficon_selected PDF is available here.
Brain and nerve = Shinkei kenkyu no shinpo (62)11 2010
[A recalcitrant case of encephalitis with voltage-gated potassium channel antibodies].
Juichi J Fujimori, Minoru M Endo, Shigemi S Irino, Yusei Y Shiga, Hirokazu H Shiraishi, Masakatsu M Motomura, Takashi T Tanno, Kinya K Hisanaga and Yasuto Y Itoyama
Abstract
We report the case of a 65-year-old man who had encephalitis with a high titer of voltage-gated potassium channel antibodies (VGKC-Abs). His initial symptoms included memory disturbance, confusion, and seizures. Laboratory tests revealed a low plasma sodium concentration and a strong positive result... | PMID: 21068462

Large_pdficon_selected PDF is available here.
Autoimmunity (43)7 2010
Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease.
Todd M Covey, Alessandra Cesano and David R Parkinson
Abstract
We describe the potential of SCNP to inform on the biological characterization of autoimmune disease, the application in clinical medicine, and the utility in drug development.... | PMID: 20482423

Large_pdficon_selected PDF is available here.
Autoimmunity (43)7 2010
Development of small-molecule therapies for autoimmune diseases.
Roland W Bürli, Alan F Haughan and Alastair J Hodges
Abstract
We herein describe the preclinical stages of typical small-molecule research programmes and outline hurdles that may have to be overcome. A few examples of small molecules that are currently under clinical evaluation and arose from diverse discovery pathways will be discussed.... | PMID: 20388059

Large_pdficon_selected PDF is available here.
Nature (467)7318 2010
Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.
Kamran Ghoreschi, Arian Laurence, Xiang-Ping Yang, Cristina M Tato, Mandy J McGeachy, Joanne E Konkel, Haydeé L Ramos, Lai Wei, Todd S Davidson, Nicolas Bouladoux, John R Grainger, Qian Chen, Yuka Kanno, Wendy T Watford, Hong-Wei Sun, Gérard Eberl, Ethan M Shevach, Yasmine Belkaid, Daniel J Cua, Wanjun Chen and John J O'Shea
Abstract
We show that T(H)17 differentiation can occur in the absence of TGF-β signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1β effectively induced IL-17 production in naive precursors, independently of TGF-β. Epigenetic modifi... | PMID: 20962846

Large_pdficon_selected PDF is available here.
PNAS (107)43 2010
Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation.
Je-Min Choi, Jae-Hun Shin, Myung-Hyun Sohn, Martha J Harding, Jong-Hyun Park, Zuzana Tobiasova, Da-Young Kim, Stephen E Maher, Wook-Jin Chae, Sung-Ho Park, Chun-Geun Lee, Sang-Kyou Lee and Alfred L M Bothwell
Abstract
We have generated a cell-permeable Foxp3 protein by fusion with the unique human HHph-1-PTD (protein transduction domain), examined its regulatory function in T cells, and characterized its therapeutic effect in autoimmune and allergic disease models. HHph-1-Foxp3 was rapidly and effectively transdu... | PMID: 20937878

Large_pdficon_selected PDF is available here.
Nature Biotechnology (28)10 2010
Epigenetic modifications and human disease.
Anna Portela and Manel Esteller
Abstract
We are learning how aberrant placement of these epigenetic marks and mutations in the epigenetic machinery is involved in disease. Thus, a comprehensive understanding of epigenetic mechanisms, their interactions and alterations in health and disease, has become a priority in biomedical research.... | PMID: 20944598

Large_pdficon_selected PDF is available here.
MMW Fortschritte der Medizin (152)39 2010
[Psoriasis. More than flaky plaque].
Martin Bischoff
Abstract
PMID: 21053516

Large_pdficon_selected PDF is available here.
Cornea (29)10 2010
Distinct dacryoadenitides autoadoptively transferred to rabbits by different subpopulations of lymphocytes activated ex vivo.
Padmaja B Thomas, Deedar M Samant, Yanru Wang, Shivaram Selvam, Douglas Stevenson, John D Gray, Joel E Schechter, Austin K Mircheff and Melvin D Trousdale
Abstract
To test whether CD4+ T cells proliferate in mixed cell reactions with autologous lacrimal gland (LG) acinar cells and whether these cells can autoadoptively transfer disease. Purified acinar cells were gamma irradiated and cocultured with peripheral blood lymphocytes. Activated CD4+ T cells were sor... | PMID: 20577087

Large_pdficon_selected PDF is available here.
Autoimmunity Reviews (9)12 2010
Autoimmunity in 2009.
Carlo Selmi
Abstract
The number of 2009 publications in indexed journals dealing with 'autoimmunity' has maintained its increasing trend compared to the previous five years. Numerous developments have been proposed in our understanding of systemic and organ-specific autoimmune diseases (particularly mult... | PMID: 20716447

Large_pdficon_selected PDF is available here.
IMAJ (12)10 2010
Infections more than vaccines are inducers of autoimmune diseases.
Elias Toubi
Abstract
PMID: 21090523

Large_pdficon_selected PDF is available here.
Annals of Medicine (42)7 2010
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974.
Carlo Catassi, Debby Kryszak, Bushra Bhatti, Craig Sturgeon, Kathy Helzlsouer, Sandra L Clipp, Daniel Gelfond, Elaine Puppa, Anthony Sferruzza and Alessio Fasano
Abstract
We analyzed 3,511 subjects with matched samples from 1974 (CLUE I) and 1989 (CLUE II). To avoid a selection bias regarding survival, we also screened 840 CLUE I participants who deceased after the 1974 survey. Outcome measure. CD autoimmunity (positivity to auto-antibodies) over time. CD autoimmunit... | PMID: 20868314

Large_pdficon_selected PDF is available here.